News Context At a glance Original source: onclive.com Brandon G. Smaglo, MD, FACP, discusses advancements in therapies for pancreatic cancer driven by a better understanding of RAS mutations. He highlights the potential of new RAS-targeted treatments to change how patients and providers perceive this diagnosis, moving it from a death sentence to something manageable and … Continue reading Unlocking New RAS Inhibitor Therapies for Enhanced Pancreatic Cancer Treatment